HansaBioMed Life Sciences
Click to enlarge
HansaBioMed Life Sciences OÜ

ExoTEST for Tumor-derived Exosome enrichment and quantification from human plasma

Available - In Stock

ExoTEST is a sandwich enzyme-linked immunoassay for in-vitro exosome quantification in human serum, plasma and urine.

Standard
HBM-RTK-PTF/TC
€670.00

Price excludes VAT

Product Details

Product Overview

ExoTEST is a patented double sandwich ELISA assay for quantitative and qualitative analysis of exosomes. In particular ExoTEST is a successful platform for exosome quantification and characterization from small amount of human biological fluids or cell media and it may be exploited to identify exosomes released by cancer cells in the plasma and urine of tumor patients in various disease conditions.

 

ExoTEST consists in ELISA plates pre-coated with proprietary pan-exosome antibodies enabling specific capture of exosomes from different biological samples, including cell culture supernatants and human biological fluids. Quantification and characterization of exosomal proteins is subsequently performed using appropriate detection antibodies against exosome associated antigens that can be for either generic or cell/tissue-specific exosomes. Lyophilized exosome standards, characterized for protein content and particle number (NTA) allow the quantification of unknown sample by a standard calibration curve.

Sample type: Plasma
:

ELISA

All documents are provided in PDF format for easy viewing and printing. For additional technical documentation, please contact our support team.

No reviews yet

Be the first to review this product!

Related Products

You may also be interested in